6-Bromo-N-methyl-2-naphthamide, 95.0%, 5g

6,6'-Dichloro-4,4'-dimethyl-3H,3'H-[2,2'-bibenzo[b]thiophenylidene]-3,3'-dione, 95.0%, 250mg

1-Methyl-3-octyl-imidazolium-, tetrafluoroborate >99%, 100 g, glass packaging

(4-Bromo-2,5-dimethoxyphenyl)boronic acid, 95.0%, 5g

(S)-1-(3-Fluoro-4-methylphenyl)ethanamine hydrochloride, 97.0%, 1g

5-nitro-2-(trifluoromethyl)-1,3-diazinane-4,6-dione, 98%, 1g

Methyl 4-bromo-2-formylbenzoate, 97%, 1g

Ethylcyclohexane, 95.0%, 500ml

2-(2,6-Dioxopiperidin-3-yl)-4-iodoisoindoline-1,3-dione, 97%, 1g

(R)-tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate, 98%, 5g

1,1,3-Trimethyl-2,3-dihydro-1H-inden-4-amine hydrochloride, 97%, 250mg

2-Fluoro-5-methoxyphenylboronic acid, 98.0%, 10g

3,3-Difluoro-5-nitroindolin-2-one, 98%, 250mg